Ann: Shareholder Webinar, page-9

For those that may interested in looking forward and realise that this is a turnaround stock, and before I get howled down. I am one of those long term investors so now is a good time for all the down rampers to switch off.
I rang to ask directly a few questions

Q; Has anything changed on the future funding risk for a CR
A; No, as stated NO CR ,which has been continuously stated by others on this forum so again NO CR.

Q; Does the Company think it is on track
A; YES, nothing new really

There was more general conversation with a note in my mind of ,
HSV-2 , the outcome release timing unchanged at a few months time however, the second group's
treatment has been tweaked on reviewing the first cohort to hopefully increase efficiency which makes sense and will hopefully allow more understanding of dosage requirements (my words).
I know some will not contact the company and again that's their call, however until I have a reason not to I will continue. The day that I don't trust the company is the day the sell button is hit. GLTA.